Prospective evaluation of serum amiodarone concentrations when administered via a nasogastric tube into the stomach conduit after transthoracic esophagectomy

Clinical Therapeutics

Volumn 29, Issue 10, 2007, Pages 2226-2234

  Tisdale, James E ^a,b   Wroblewski, Heather A ^a   Hammoud, Zane T ^b   Rieger, Karen M ^b   Young, Jerry V ^b   Wall, Donna S ^b   Kesler, Kenneth A ^b  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROL GROUP; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INFUSION; DRUG WITHDRAWAL; ESOPHAGUS RESECTION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; LUNG RESECTION; MALE; NASOGASTRIC TUBE; POPULATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; RACE; SEX; STATISTICAL SIGNIFICANCE; STOMACH; THORAX SURGERY; TRANSTHORACIC ESOPHAGECTOMY; WEIGHT;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; BIOLOGICAL AVAILABILITY; DRUG ADMINISTRATION ROUTES; ESOPHAGECTOMY; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INDIANA; INTUBATION, GASTROINTESTINAL; MALE; MIDDLE AGED; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STOMACH;

EID: 36248986713     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.10.002     Document Type: Article

References (33)

1. Holscher A., Voit H., Buttermann G., and Siewert J. Function of intrathoracic stomach as esophageal replacement. World J Surg 12 (1988) 835-844
2. Lee H., Kim M., Lee J., et al. Intrathoracic gastric emptying of solid food after esophagectomy for esophageal cancer. Ann Thorac Surg 80 (2005) 443-447
3. Amar D., Burt M., Bains M., and Leung D. Symptomatic tachydysrhythmias after esophagectomy: Incidence and outcome measures. Ann Thorac Surg 61 (1996) 1506-1509
4. Vaporciyan A., Correa A., Rice D., et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: Analysis of 2588 patients. J Thorac Cardiovasc Surg 127 (2004) 779-786
5. Konno O., Tezuka T., Muto A., et al. Postoperative arrhythmia after operation of esophageal cancer [in Japanese]. Nippon Kyobu Geka Gakkai Zasshi 41 (1993) 45-51
6. Ma J., Wang Y., Zhao Y., et al. Atrial fibrillation after surgery for esophageal carcinoma: Clinical and prognostic significance. World J Gastroenterol 12 (2006) 449-452
7. Polanczyk C., Goldman L., Marcantonio E., et al. Supraventricular arrhythmia in patients having noncardiac surgery: Clinical correlates and effect on length of stay. Ann Intern Med 129 (1998) 279-285
8. Daoud E., Strickberger S., Man K., et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337 (1997) 1785-1791
9. Giri S., White C., Dunn A., et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): A randomised placebo-controlled trial. Lancet 357 (2001) 830-836
10. White C., Caron M., Kalus J., et al., Atrial Fibrillation Suppression Trial II. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: The Atrial Fibrillation Suppression Trial II (AFIST II). Circulation 108 Suppl 1 (2003) II200-II206
11. Mitchell L., Exner D., Wyse D., et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: A randomized controlled trial. JAMA 294 (2005) 3093-3100
12. Kowey P., Marinchak R., Rials S., and Filart R. Intravenous amiodarone. J Am Coll Cardiol 29 (1997) 1190-1198
13. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [WMA Web site]. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the 52nd WMA General Assembly, Edinburgh, Scotland, October 2000.Accessed June 2007.
14. http://www.wma.net/e/policy/b3.htm
15. European Agency for the Evaluation of Medicinal Products, International Conference on Harmonisation-World Health Organization. Guideline for Good Clinical Practice [EMEA Web site]. ICH Topic E6. Geneva, Switzerland: WHO; 2002. Accessed June 2007.
16. http://www.emea.eu.int
17. Juenke J., Brown P., McMillin G., and Urry F. A rapid procedure for the monitoring of amiodarone and Ndesethylamiodarone by HPLC-UV detection. J Anal Toxicol 28 (2004) 63-66
18. Armitage P., Berry G., and Mathews J. Statistical Methods in Medical Research. 4th ed (2002), Blackwell Publishing, Oxford, UK
19. Meng X., Mojaverian P., Doedee M., et al. Bioavailability of amiodarone tablets administered with and without food in healthy subjects. Am J Cardiol 87 (2001) 432-435
20. Collard J., Romagnoli R., Otte J., and Kestens P. The denervated stomach as an esophageal substitute is a contractile organ. Ann Surg 227 (1998) 33-39
21. Collard J., Romagnoli R., Otte J., and Kestens P. Erythromycin enhances early postoperative contractility of the denervated whole stomach as an esophageal substitute. Ann Surg 229 (1999) 337-343
22. Okada N., Nishimura O., Sakurai T., et al. Gastric functions in patients with the intrathoracic stomach after esophageal surgery. Ann Surg 204 (1986) 114-121
23. Martin-Algarra R., Pascual-Costa R., Merino M., and Casabo V. Intestinal absorption kinetics of amiodarone in rat small intestine. Biopharm Drug Dispos 18 (1997) 523-532
24. Moore F., Feliciano D., Andrassy R., et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications .The results of a meta-analysis. Ann Surg 216 (1992) 172-183
25. Gabor S., Renner H., Matzi V., et al. Early enteral feeding compared with parenteral nutrition after oesophageal or oesophagogastric resection and reconstruction. Br J Nutr 93 (2005) 509-513
26. Hjelms E., Thirup P., and Schou L. Gastric intrinsic factor production and vitamin B12 absorption after oesophageal resection using stomach as substitute. Eur J Cardiothorac Surg 16 (1999) 273-275
27. Elfant A., Levine S., Peikin S., et al. Bioavailability of medication delivered via nasogastric tube is decreased in the immediate postoperative period. Am J Surg 169 (1995) 430-432
28. Kennedy J., and van Rij A. Drug absorption from the small intestine in immediate postoperative patients. Br J Anaesth 97 (2006) 171-180
29. Kotake T., Takada M., Goto T., et al. Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration. J Clin Pharm Ther 31 (2006) 237-243
30. Riva E., Gerna M., Latini R., et al. Pharmacokinetics of amiodarone in man. J Cardiovasc Pharmacol 4 (1982) 264-269
31. Shayeganpour A., El-Kadi A., and Brocks D. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: The contribution of cytochrome P450 3A isoforms. Drug Metab Dispos 34 (2006) 43-50
32. Martinez C., Albet C., Agundez J., et al. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2receptor antagonists. Clin Pharmacol Ther 65 (1999) 369-376
33. Atkins B., Shah A., Hutcheson K., et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg 78 (2004) 1170-1176